Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 911-915-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The LD50 of Olaflur is 929 mg/kg bw (male mice) and 608 mg/kg bw (female rats) after single oral administration.
Based on the available data (acute oral toxicity data, physico-chemical properties and data from toxicokinetic studies), the results for an acute dermal study were extrapolated using a route-to-route approach.
Based on this a dermal LD50 of > 2000 mg/kg bw (6080 mg/kg bw) was derived.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 608 mg/kg bw
Additional information
Oral
Key study
Male Carworth Farms CF-1S mice, weighing between 18 and 26 g were used in this study by Menley & James, 1969. The animals were dosed orally at 500, 625, 750, 1000, 1250, 1500 or 1750 mg/kg bw (as base) in a dose volume of 10 or 30 mL/kg bw distilled water. The 500 - 1000 mg/kg bw doses were given at 10 mL/kg bw. As the data was insufficient to calculate an LD50, additional higher doses were tested. A 30 mL/kg bw was used for these higher doses. Controls received distilled water at 10 and 30 mL/kg bw. Ten animals per dose were tested. The mice were observed for seven consecutive days for death and the LD50 with 95% Fieller confidence Limits was calculated, resulting in 929 mg/kg bw.
Key study
Female Charles River rats, weighing between 100 and 155 g, were used in this study by Menley & James, 1969.
The animals were dosed orally at 500, 625, 750 or 1000 mg/kg bw (as base) in a dose volume of 10 mL/kg bw distilled water. Controls received distilled water at 20 mL/kg bw. Ten animals per dose were tested. In general, the rats were observed for seven consecutive days for death. Due to the death of the animal dosed at 750 mg/kg bw the study was continued two additional days. No additional animals died during that period. The LD50 with 95% Fieller confidence Limits was calculated to be 608 mg/kg bw.
Dermal
No experimental study investigating the acute dermal toxicity of Olaflur is available.
However, a reliable prediction of the potential acute dermal toxicity and the respective classification and labelling of the substance is possible based on the physico-chemical properties of the test substance and data generated in other toxicological studies. Therefore, performing a new dermal toxicity study would not be in line with animal welfare ideas nor is the exposure pathway relevant to consumers or workers.
Acute dermal LD50 extrapolation:
Olaflur revealed oral LD50 values in acute studies of 929 mg/kg bw in mice and 608 mg/kg bw in rats, respectively. However, it should be noted that the observed effects are at least partially linked to local tissue damage due to the mucous membrane irritation/damaging properties of the substance and so overestimating the systemic toxicity properties.
For the route to route extrapolation taking into account the physico-chemical properties and the data from toxicokinetic studies, the following assumptions can be considered as a worst case scenario:
Oral bioavailability: 100 %
Dermal bioavailability: 10 %
Acute oral toxicity: 608 mg/kg bw
Lowest LD50 value considered although lethality at least partially is linked to local tissue damage and not to systemic toxicity.
Based on this scenario a dermal LD50 of > 2000 mg/kg bw (6080 mg/kg bw) can be calculated.
Inhalation
No studies available.
According to European Commission Regulation 1907/2006, Annex VIII, Section 8.5.2, testing the acute toxicity by inhalation route is appropriate if exposure of humans via inhalation is likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size. Olaflur is a fat-like resp. wax-like mass marketed as component of pastes or fluids only – inhalation is unlikely. Thus, the study on acute toxicity by inhalation route is not relevant and can be omitted.
Justification for classification or non-classification
Based on the results obtained in the acute toxicity studies (oral: LD50: 929 mg/kg bw (mice) and 608 mg/kg bw (rats)), Olaflur has to be classified as "harmful" with respect to acute oral toxicity taking the provisions laid down in Council Directive 67/548/EEC (DSD) and Regulation (EC) No. 1272/2008 (CLP)(GHS) into consideration. According to DSD, Olaflur has to be classified as "harmful" with Xn, R22 - harmful if swallowed. According to GHS Olaflur has to be classified as "harmful if swallowed" (H302), Cat. 4. Classification and labelling with regard to acute dermal toxicity resp. acute toxicity via inhalation is not required according to Regulation (EC) No. 1272/2008 (CLP)(GHS) and Directive 67/548/EEC (DSD).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.